By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Decoy Therapeutics Inc.

Decoy Therapeutics Inc. (DCOY)

NASDAQ Fundamentals in USD
Price unavailable
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
52 Week Range

DCOY Stock Price Chart

Explore Decoy Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze DCOY price movements and trends.

DCOY Company Profile

Discover essential business fundamentals and corporate details for Decoy Therapeutics Inc. (DCOY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

29 Jan 2015

Employees

2.00

CEO

Frederick E. Pierce

Description

Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.

DCOY Financial Timeline

Browse a chronological timeline of Decoy Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

DCOY Stock Performance

Access detailed DCOY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run